Healthcare provider profile · identity verified

Evgenia Forman, M.D.

Geriatric Medicine · DORCHESTER CENTER, MA · NPI 1215042361

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1001	71
Levothyroxine Sodium	Levothyroxine Sodium	721	27
Amlodipine Besylate	Amlodipine Besylate	670	46
Mirtazapine	Mirtazapine	615	31
Eliquis	Apixaban	606	42
Furosemide	Furosemide	556	42
Trazodone Hcl	Trazodone Hcl	487	36
Metoprolol Succinate	Metoprolol Succinate	387	32
Omeprazole	Omeprazole	364	31
Gabapentin	Gabapentin	356	31
Famotidine	Famotidine	327	18
Losartan Potassium	Losartan Potassium	323	19
Metformin Hcl	Metformin Hcl	271	21
Divalproex Sodium	Divalproex Sodium	260	12
Sertraline Hcl	Sertraline Hcl	257	14
Lisinopril	Lisinopril	248	19
Spironolactone	Spironolactone	245	17
Carvedilol	Carvedilol	224	14
Risperidone	Risperidone	221	12
Metoprolol Tartrate	Metoprolol Tartrate	195	22
Tamsulosin Hcl	Tamsulosin Hcl	193	20
Citalopram Hbr	Citalopram Hydrobromide	184	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	175	14
Escitalopram Oxalate	Escitalopram Oxalate	154	suppressed
Torsemide	Torsemide	147	17
Allopurinol	Allopurinol	143	13
Jardiance	Empagliflozin	142	11
Levetiracetam	Levetiracetam	130	14
Memantine Hcl	Memantine Hcl	122	suppressed
Donepezil Hcl	Donepezil Hcl	121	13
Quetiapine Fumarate	Quetiapine Fumarate	120	16
Bupropion Xl	Bupropion Hcl	119	suppressed
Atenolol	Atenolol	116	suppressed
Glipizide	Glipizide	113	suppressed
Montelukast Sodium	Montelukast Sodium	110	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	105	suppressed
Olanzapine	Olanzapine	100	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	100	suppressed
Warfarin Sodium	Warfarin Sodium	97	suppressed
Lactulose	Lactulose	95	21
Paroxetine Hcl	Paroxetine Hcl	95	suppressed
Oxycodone Hcl	Oxycodone Hcl	93	18
Januvia	Sitagliptin Phosphate	90	suppressed
Duloxetine Hcl	Duloxetine Hcl	88	suppressed
Simvastatin	Simvastatin	85	suppressed
Colchicine	Colchicine	82	suppressed
Baclofen	Baclofen	71	suppressed
Benztropine Mesylate	Benztropine Mesylate	71	suppressed
Potassium Chloride	Potassium Chloride	71	12
Jantoven	Warfarin Sodium	67	suppressed
Ropinirole Hcl	Ropinirole Hcl	67	suppressed
Sucralfate	Sucralfate	66	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	65	suppressed
Methenamine Hippurate	Methenamine Hippurate	63	suppressed
Valsartan	Valsartan	63	suppressed
Alendronate Sodium	Alendronate Sodium	61	suppressed
Bupropion Hcl Sr	Bupropion Hcl	61	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	60	11
Entresto	Sacubitril/Valsartan	59	suppressed
Prazosin Hcl	Prazosin Hcl	56	suppressed
Finasteride	Finasteride	55	suppressed
Bumetanide	Bumetanide	54	suppressed
Pravastatin Sodium	Pravastatin Sodium	54	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	53	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	52	suppressed
Clopidogrel	Clopidogrel Bisulfate	52	suppressed
Prednisone	Prednisone	52	suppressed
Perphenazine	Perphenazine	50	suppressed
Savella	Milnacipran Hcl	49	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	45	suppressed
Bupropion Hcl	Bupropion Hcl	45	suppressed
Digoxin	Digoxin	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	43	12
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	40	15
Fluticasone Propionate	Fluticasone Propionate	38	15
Azithromycin	Azithromycin	35	suppressed
Lithium Carbonate	Lithium Carbonate	35	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	33	suppressed
Lansoprazole	Lansoprazole	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Trospium Chloride	Trospium Chloride	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Ramelteon	Ramelteon	30	suppressed
Latanoprost	Latanoprost	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Hydrocortisone	Hydrocortisone	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Timolol Maleate	Timolol Maleate	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	16
Farxiga	Dapagliflozin Propanediol	24	suppressed
Humulin R	Insulin Regular, Human	24	suppressed
Insulin Lispro	Insulin Lispro	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Memantine Hcl Er	Memantine Hcl	24	suppressed
Ursodiol	Ursodiol	24	suppressed
Cephalexin	Cephalexin	23	13
Dofetilide	Dofetilide	23	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	23	suppressed
Levofloxacin	Levofloxacin	23	14
Naltrexone Hcl	Naltrexone Hcl	23	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	suppressed
Morphine Sulfate	Morphine Sulfate	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Hydroxyurea	Hydroxyurea	20	suppressed
Prednisolone Acetate	Prednisolone Acetate	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	19	13
Ezetimibe	Ezetimibe	19	suppressed
Methylprednisolone	Methylprednisolone	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Novolog	Insulin Aspart	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Tacrolimus	Tacrolimus	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Humalog	Insulin Lispro	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Entecavir	Entecavir	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	12	suppressed
Clozapine	Clozapine	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Droplet Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error